Premium
Hepatitis C Virus Genotypes 1a and 1b Mixed Infections
Author(s) -
Soriano V.,
Bravo R.,
GarcíaSamaniego J.
Publication year - 1997
Publication title -
vox sanguinis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.68
H-Index - 83
eISSN - 1423-0410
pISSN - 0042-9007
DOI - 10.1046/j.1423-0410.1997.00064.x
Subject(s) - hepatitis c virus , genotype , virology , flaviviridae , population , hepatitis c , residence , medicine , virus , demography , immunology , biology , environmental health , genetics , sociology , gene
In response to Poljak and Seme's letter, we would like to point out that the manuscript published in another journal [1], although based on the same study population, was only meant to discuss the results of Pawlotsky et al. [2], who claimed that hepatitis C virus (HCV) genotype 3a was the predominant type among injecting drug users (IDUs) in France, and most likely, in Western Europe. In light of their results, the French authors suggested that HCV‐3a might have been introduced recently in Europe, most likely through IDUs, and that a potential source of infection in Central Asia e.g. (Nepal), where HCV‐3a is prevalent, could explain the linkage, since residence in this region was in vogue in the 1970s among young people with ‘alternative’ life styles. We did not confirm this observation since in Spain HCV‐1a was the predominant subtype found in IDUs.